Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is ...

Please provide your email address to receive an email when new articles are posted on . Patients with melanoma who have a decrease in ctDNA 3 to 4 weeks after immunotherapy had improved outcomes.

AI is changing care for melanoma patients but one major flaw still threatens the promise.

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at ...

Maintaining normal vitamin D levels may improve the efficacy of immunotherapy in patients with advanced melanoma, a new study suggests. The finding comes from a study of 200 patients with melanoma who ...

New research has linked higher plasma levels of the healthy fats omega-3 and omega-6 to a reduced risk of developing particular types of cancer. The study adds to the on-again/off-again relationship ...